Admission Date:  [**2183-1-7**]              Discharge Date:   [**2183-2-14**]  Date of Birth:  [**2125-8-6**]             Sex:   M  Service: CARDIOTHORACIC  Allergies: Morphine  Attending:[**First Name3 (LF) 165**] Chief Complaint: transfered from OSH for MRSA bacteremia/endocarditis in the setting of osteomyeltitis  Major Surgical or Invasive Procedure: MVR (27mm [**First Name8 (NamePattern2) **] [**First Name5 (NamePattern1) 923**] [**Last Name (NamePattern1) 16409**] valve) [**1-24**]   History of Present Illness: The patient is a 57 y/o male w hx of DM, PVD s/p R TMA [**8-14**], b/l charcot joints, CKD, HTN, who is tranfered from an OSH after finding of MRSA bacteremia/endocarditis.
In [**Month (only) 216**], he underwent a R TMA, complicated by persistent wound infections requring a treatment course of Bactrim for MRSA and a wound VAC.
Because of persistent fevers and bacteremia, a TEE was ordered and reportedly showed a soft density on mitral valve and suggestion of an aortic valve leaflet density consistent with endocarditis.
Patient had a tunneled central venous line under fluroscopic guidance the day prior to transfer.
His DKA was initially treated with an insulin gtt, but blood sugars were adequatly controlled with NPH and a sliding scale over the hospitaliztion.
Past Medical History: Multiple lower extremity infections, wounds Diabetes II - poorly controlled Peripheral Neuropathy Hypertention Chronic Renal Failure (1.8-2.2 Creat) Left TMA Right 1st and 4th toe amp Anemia  Social History: Non-smoker, NO etoh [**Company 16410**] Ship Inspector, but not currently working   Family History: Mother died from alzheimer's, father died from heart attack, sister has DM and hx of MRSA infection  Physical Exam: vs: Tc 100.9 BP 136/62 HR 84 O2 95% on RA Gen: Obese male in NAD, AAOx3 HEENT: PERRL, EOMI, MMM, no LAD, OP w/o exudates or erythema Chest: CTA b/l, no CVA tenderness, site of tunnel catheter c/d/i Cardiac: RRR, s1,s2, soft II/VI blowing systolic murmur heard best at USB Abd: obese, soft ntnd, no HSM Extremities: The RLE wound is deep, but dry and w/o drainaige.
Pertinent Results: [**2183-2-13**] 05:37AM BLOOD WBC-9.5 RBC-3.09* Hgb-8.2* Hct-27.3* MCV-89 MCH-26.7* MCHC-30.1* RDW-18.8* Plt Ct-390 [**2183-2-14**] 03:51AM BLOOD PT-25.1* PTT-98.9* INR(PT)-2.5* [**2183-2-14**] 03:51AM BLOOD Glucose-99 UreaN-37* Creat-3.2* Na-131* K-5.2* Cl-100 HCO3-24 AnGap-12  Brief Hospital Course: A/P Pt is a 57 y/o male w hx of DM, PVD s/p R TMA [**8-14**], b/l charcot joints, CKD, HTN, who is transferred from an OSH after finding of MRSA bacteremia/endocarditis in the setting of osteomyelitis of b/l metatarsals.
TEE here shows large MV veg with probable perf of posterior leaflet and 3+ MR. [**Name13 (STitle) **] has been on vacomycin since [**2182-12-23**], but has been unable to clear bacteremia.
He was transferred to the ICU in stable condition on amiodarone, vasopressin, milrinone, levophed, neo, propofol and insulin.
He continued on daptomycin and gentamycin.
He was started on coumadin and heparin IV for his mechanical valves.
Bactrim was added, and was then changed to rifampim given his nausea.
He was started on meropenum for GNR in blood.
Medications on Admission: Medications on Transfer: vancomycin 1500mg IV q48 h ASA 81mg daily Colace 100mg [**Hospital1 **] Iron 300mg [**Hospital1 **] Lisinopril 20mg [**Hospital1 **] Toprol XL 200mg qam Senokot [**Hospital1 **] Lantus 40units qhs NPH 14 units qam Regular insuln 7 units qafternoon regular 14 units qam ISS Reglan PRN Tylenol PRN  Discharge Medications: 1.
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Famotidine 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed.
Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Epoetin Alfa 10,000 unit/mL Solution Sig: One (1)  Injection QMOWEFR (Monday -Wednesday-Friday).
Daptomycin 500 mg Recon Soln Sig: Eight Hundred (800) mg Intravenous Q48H (every 48 hours) for 4 weeks: 4 weeks from [**1-31**].
Rifampin 300 mg Capsule Sig: One (1) Capsule PO Q 8H (Every 8 Hours) for 4 weeks: 4 weeks from [**1-31**].
Meropenem 1 gram Recon Soln Sig: One (1) Recon Soln Intravenous Q12H (every 12 hours) for 4 weeks: 4 weeks from [**2-2**].
Insulin Glargine 100 unit/mL Solution Sig: Twenty Five (25) units Subcutaneous at bedtime.
Insulin Lispro 100 unit/mL Solution Sig: sliding scale Subcutaneous four times a day.
Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed.
Warfarin 1 mg Tablet Sig: Three (3) Tablet PO ONCE (Once) for 1 doses: titrate dose daily for a goal INR of 2.5 to 3 for a mechanical mitral valve.
Lasix 20 mg Tablet Sig: Two (2) Tablet PO once a day for 10 days: reassess fluid level at end of course to guide need to continue.
Wound Continue wound VAC to foot for one week   Discharge Disposition: Extended Care  Facility: [**Hospital **] Health Care - [**Hospital1 **]  Discharge Diagnosis: mitral valve endocarditis now s/p MVR acute on chronic renal failure Right foot osteomyelitis s/p debridement and VAC placement multiple lower extremity infections, DM2, peripheral neuropathy, HTN, CRI(1.8-2.2), L TMA, R TMA, anemia   Discharge Condition: Stable   Discharge Instructions: Call with fever, redness or drainage from incision or weight gain more than 2 pounds in one day or five in one week.
Shower daily, no baths, no lotions, creams or powders to incisions.
